LEYTHERS are being called upon to take part in a pioneering study which aims to halt the effects of prodromal Alzheimer’s disease.
The 5 boroughs partnership are the only organisation in the North West taking part and one of only a few across the country.
The SCarlet RoAD study is a research study of an investigational medication for the treatment of prodromal Alzheimer’s disease (prodromal AD).
Prodromal AD is a condition in which a person’s memory loss is worse than can be expected by the normal ageing process alone, even though their ability to get on with daily activities is not affected to such an extent that they would be diagnosed with dementia.
It is estimated that there are around 3,000 people in Wigan who currently battle with Alzhaimer’s disease.
The symptoms of prodromal AD can include a person’s inability to recall events in his/her recent past.
The new vaccine would be trialled over a two-and-a-half year period being taken once a month.
The study investigators are looking for study participants who:
• Are aged between 50 and 85 years
• Have noticed (and someone else has noticed) a gradual decline in memory over the last 12 months
• Are not currently taking any medications for dementia or Alzheimer’s disease
• Have a friend or relative who is able to say how they are managing with daily activities and who is willing to provide information at clinic visits when appropriate
• Are interested in participating in a study that lasts for two years and five months and which will involve visits to a clinic at least once every month throughout this period
Those who believe they may be eligible to participate, or who know someone who may be eligible, should visit the website at www.scarletroadstudy.com or call 0808 189 1497 for more information.